28 August 2020 – First clinical trial for vaccine authorised in Spain

Type of Intervention: Specific Action
Sectors Involved: Health
Level of Jurisdiction: National
Lead People/Agency: Ministry of Health and the Spanish Agency for Medication and Health Products (Spanish acronym: AEMPS)

Overview: First clinical trial for vaccine against COVID-19 authorised in Spain
The Spanish Agency for Medication and Health Products (Spanish acronym: AEMPS) authorised the clinical trial in Spain of the vaccine by the company Janssen (a Johnson & Johnson company) – the first of this type in our country. This is a phase 2a trial that is scheduled to include a total of 550 healthy volunteers, of which 190 will be recruited in Spain at three hospital centres.
Full details here: https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/2020-medicamentosusohumano-3/la-aemps-autoriza-el-primer-ensayo-clinico-para-la-vacuna-contra-la-covid-19-en-espana/

Type of Justification: Advice of INTERNAL government advisory committee or group
Source of Evidence or Justification: National – academic, National – government, National – other, International – academic, European Union